DMD: Vasodilator Drug Study Needs Four Boys

A study of the effects of two drugs on blood flow to exercising muscles needs four more boys with Duchenne MD in order to be complete

Article Highlights:
  • A drug study is seeking four participants with Duchenne muscular dystrophy who are between the ages of 7 and 15 years and still walking.
  • The study is looking at two FDA-approved drugs — tadalafil and sildenafil  both of which may improve the ability of muscle fibers to increase blood flow during exercise.
  • Participants must travel to Los Angeles; all travel expenses are covered.
by Margaret Wahl on February 7, 2013 - 5:00am

A 12-participant study of the acute effects of two vasodilating drugs on blood flow to exercising muscles needs four more boys with Duchenne muscular dystrophy (DMD) who meet study criteria and are able to travel to Los Angeles. Vasodilators increase the diameter of blood vessels.

"We’ve made some wonderful progress with our latest Duchenne MD blood flow studies investigating the effects of tadalafil," said Sharon Tang, clinical research coordinator for the study. "In order to complete this exciting project, we only need four more boys. The study only requires one week of study visits in sunny Los Angeles. All travel expenses are covered by the study. Get away from your winter blues and help make us make a difference!"

The study involves taking two doses of each of two drugs — tadalafil and sildenafil — both of which may improve the ability of muscle fibers to increase blood flow during exercise despite the presence of a DMD-causing mutation in the dystrophin gene.

Participants must:

  • have a diagnosis of DMD;
  • be 7 to 15 years old;
  • be able to walk; and
  • be without clinical signs of heart failure.

The trial will involve measuring blood flow in exercising forearm muscles and blood medication levels during two sets of visits to Cedars-Sinai Medical Center in Los Angeles, approximately one week apart.

For details, see PDE Inhibitors in DMD (Acute Dosing Study); or enter NCT01580501 in the search box at ClinicalTrials.gov.

Prospective participants should contact Sharon Tang in Los Angeles at (310) 248-8080 or Sharon.Tang@cshs.org.

About Clinical Trials

About Clinical Trials

A clinical trial is a test, in humans, of an experimental treatment. Although it's possible that benefit may be derived from participating in a clinical trial, it's also possible that no benefit, or even harm, may occur.

MDA has no ability to influence who is chosen to participate in a clinical trial.

To learn more, see Learn About Clinical Studies and Being a Co-Adventurer, which is about neuromuscular disease clinical trials. To see a continuously updated database of clinical trials, go to ClinicalTrials.gov.

Your rating: None Average: 5 (1 vote)
MDA cannot respond to questions asked in the comments field. For help with questions, contact your local MDA office or clinic or email publications@mdausa.org. See comment policy